BE455296A - - Google Patents
Info
- Publication number
- BE455296A BE455296A BE455296DA BE455296A BE 455296 A BE455296 A BE 455296A BE 455296D A BE455296D A BE 455296DA BE 455296 A BE455296 A BE 455296A
- Authority
- BE
- Belgium
- Prior art keywords
- salts
- glyoxylic acid
- compounds
- thiazol
- reaction
- Prior art date
Links
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 125000004404 heteroalkyl group Chemical group 0.000 claims 1
- SOEVVANXSDKPIY-UHFFFAOYSA-M sodium glyoxylate Chemical compound [Na+].[O-]C(=O)C=O SOEVVANXSDKPIY-UHFFFAOYSA-M 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 claims 1
- 150000003456 sulfonamides Chemical group 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- 239000000047 product Substances 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- KINFJLYCWPTJRB-UHFFFAOYSA-N 2,2-diacetyloxyacetic acid Chemical compound CC(=O)OC(C(O)=O)OC(C)=O KINFJLYCWPTJRB-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 101150029855 selB gene Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE455296A true BE455296A (de) |
Family
ID=109242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE455296D BE455296A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE455296A (de) |
-
0
- BE BE455296D patent/BE455296A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3085208C (en) | Enantiomeric separation of racemic nicotine by addition of an o,o'-disubstituted tartaric acid enantiomer | |
| BE1013213A6 (fr) | Procede de preparation de citalopram pur. | |
| CA1306261C (fr) | 1,4-dihydropyridines, leur procede de preparation et leur application comme medicaments | |
| EP0040591A1 (de) | Pyridoxin-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung | |
| EP0332530A1 (de) | Polymere aus Zitronensäure und Diaminen, Verfahren zu deren Herstellung und deren Anwendung als Arzeimittelvektoren | |
| CH641181A5 (fr) | Indolo-quinolizidines, procede pour leur preparation et compositions therapeutiques les contenant. | |
| EP0063509A1 (de) | 2-Piperazino-pyrimidin-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel und ihre Verwendung als Zwischenprodukte zur Herstellung von Arzneimitteln | |
| CH630606A5 (en) | Phenylamidine derivatives useful especially in therapeutics | |
| DE60007835T2 (de) | Verfahren zur herstellung von chiralen aminosäuren | |
| EP0094283B1 (de) | Arzneimittelform von Theophyllin mit verlängerter Wirkung | |
| EP0117171B1 (de) | Aminoderivate von in Stellung 6 durch ein heterocyclisch oder ein alicyclisch substituiertes Pyridazin, Verfahren zu deren Herstellung und Heilmittel die sie enthalten | |
| WO1981002295A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant | |
| BE653101A (de) | ||
| MC1568A1 (fr) | Derives de benzamide | |
| CH406194A (fr) | Procédé de préparation de sels stables de diméthylcarboxy-alkylsulfonium | |
| BE528076A (de) | ||
| BE624576A (de) | ||
| BE499168A (de) | ||
| CH477399A (fr) | Procédé de production de 2-méthylamino-2-(o-chlorophényl)cyclohexanone | |
| BE534468A (de) | ||
| BE513091A (de) | ||
| BE881709A (fr) | Phosphate de d-glaucine, sa preparation et son utilisation | |
| BE633464A (de) | ||
| WO2003011856A1 (fr) | Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique | |
| BE345504A (de) |